← All companies

CUBT

Curative Biotechnology, Inc.

CUBT OTC Biological Products, (No Diagnostic Substances) EDGAR ↗

$0.93

-0.07 -7.10%

Key statistics

from XBRL data in SEC filings

Market cap ⓘ

—

Revenue (TTM) ⓘ

—

Net income (TTM) ⓘ

—

EPS (TTM) ⓘ

—

P/E ratio ⓘ

—

Dividend yield ⓘ

—

Free cash flow ⓘ

—

Cash ⓘ

—

Total assets ⓘ

—

Gross margin ⓘ

—

52-week range ⓘ

$0.03 – $1.99

Recent SEC filings

40 most recent

Other filings

RW Dec 22, 2025

S-1/A Aug 1, 2025

S-1 May 6, 2024

S-1/A Jan 25, 2023

D Item 06b Jan 18, 2023

S-1/A Jan 13, 2023

S-1/A Jan 9, 2023

8-A12B/A Dec 1, 2022

S-1/A Nov 30, 2022

S-1/A Nov 16, 2022

S-1 Nov 7, 2022

RW Oct 31, 2022

EFFECT Item S-1; Item 2022-10-13; Item 09:00:00 Oct 13, 2022

CORRESP Oct 11, 2022

CERT NYSE AMERICAN CERTIFICATION Oct 5, 2022

8-A12B Oct 5, 2022

CORRESP Sep 30, 2022

S-1/A Sep 30, 2022

UPLOAD Sep 29, 2022

S-1/A Sep 28, 2022

CORRESP Sep 9, 2022

S-1/A Sep 9, 2022

UPLOAD Sep 8, 2022

S-1/A Sep 1, 2022

CORRESP Aug 10, 2022

S-1/A Aug 10, 2022

UPLOAD Aug 8, 2022

S-1/A Aug 1, 2022

CORRESP Jul 8, 2022

S-1/A Jul 8, 2022

UPLOAD Jul 7, 2022

S-1/A Jun 29, 2022

CORRESP Apr 25, 2022

S-1/A Apr 25, 2022

UPLOAD Apr 21, 2022

CORRESP Apr 15, 2022

S-1 Apr 15, 2022

UPLOAD Apr 5, 2022

DRSLTR Mar 28, 2022